Novel subtype-selective nonpeptide bradykinin receptor antagonists FR167344 and FR173657

Molecular Pharmacology

Volumn 51, Issue 2, 1997, Pages 171-176

  Aramori, Ichiro ^a   Zenkoh, Junko ^a   Morikawa, Noriyuki ^a   O'Donnell, Nuala ^a   Asano, Masayuki ^a   Nakamura, Kozo ^a   Iwami, Morita ^a   Kojo, Hitoshi ^a   Notsu, Yoshitada ^a  

^a ASTELLAS PHARMA INC   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

3 (6 ACETAMIDO 3 PYRIDYL) N [N [2,4 DICHLORO 3 [(2 METHYL 8 QUINOLINYL)OXYMETHYL]PHENYL] N METHYLAMINOCARBONYLMETHYL]ACRYLAMIDE; 3 BROMO 8 [2,6 DICHLORO 3 [N [4 (N,N DIMETHYLCARBAMOYL)CINNAMIDOACETYL] N METHYLAMINO]BENZYLOXY] 2 METHYLIMIDAZO[1,2 A]PYRIDINE; BRADYKININ; BRADYKININ B1 RECEPTOR; BRADYKININ B2 RECEPTOR; BRADYKININ B2 RECEPTOR ANTAGONIST; ICATIBANT; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG;

ANALGESIC ACTIVITY; ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BRONCHOSPASM; CHO CELL; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; HYPOTENSION; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL;

EID: 0031037549     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.51.2.171     Document Type: Article

References (26)

1. Regoli, D., and J. Barabé. Pharmacology of bradykinin and related kinins. Pharmacol. Rev. 32:1-46 (1980).
2. Proud, D., and A. P. Kaplan. Kinin formation: mechanisms and role in inflammatory disorders. Annu. Rev. Immunol. 6:49-83 (1988).
3. Dray, A., and M. Parkins. Bradykinin and inflammatory pain. Trends Neurosci. 16:99-104 (1993).
4. 2 receptor characterization. Trends Pharmacol. Sci. 11:156-161 (1991).
5. 2 bradykinin receptor. Proc. Natl. Acad. Sci. USA 88:7724-7728 (1991).
6. Hess, J. F., J. A. Borkowski, G. S. Young, C. D. Strader, and R. W. Ransom. Cloning and pharmacological characterization of a human bradykinin (BK-2) receptor. Biochem. Biophys. Res. Commun. 184:260-268 (1992).
7. 1 bradykinin receptor. J. Biol. Chem. 269:21583-21586 (1994).
8. Hock, F. J., K. Wirth, U. Albus, W. Linz, H. J. Gerhards, G. Wiemer, S. Henke, G. Breipohl, W. König, J. Knolle, and B. A. Schölkens. Hoe140 a new potent and long acting bradykinin-antagonist: in vitro studies. Br. J. Pharmacol. 102:769-773 (1991).
9. 2 receptor antagonist. Proc. Natl. Acad. Sci. USA 91:4693-4697 (1994).
10. Hall, J. M., M. P. Caulfield, S. P. Watson, and S. Guard. Receptor subtypes or species homologues; relevance to drug discovery. Trends Pharmacol. Sci. 14:376-383 (1993).
11. 2 receptor antagonist, FR173657. Br. J. Pharmacol., in press.
12. Aramori, I., and S. Nakanishi. Coupling of two endothelin receptor subtypes to differing signal transduction in transfected Chinese hamster ovary cells. J. Biol. Chem. 267:12468-12474 (1992).
13. Graham, F. L., and A. J. van der Eb. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52:456-467 (1973).
14. Shigemoto, R., Y. Yokota, K. Tsuchida, and S. Nakanishi. Cloning and expression of a rat neuromedin K receptor cDNA. J. Biol. Chem. 265:623-628 (1990).
15. 1 receptors in rabbit aorta smooth muscle cells in culture. Eur. J. Pharmacol. 266:277-282 (1994).
16. Manning, D. C., R. Vavrek, J. M. Stewart, and S. H. Snyder. Two bradykinin binding sites with picomolar affinities. J. Pharmacol. Exp. Ther. 237:504-512 (1986).
17. Berridge, M. J., R. M. C. Dawson, C. P. Downes, J. P. Heslop, and R. F. Irvine. Changes in the levels of inositol phosphates after agonist-dependent hydrolysis of membrane phosphoinositides. Biochem. J. 212: 473-482 (1983).
18. Arunlakshana, O., and H. O. Schild. Some quantitative uses of drug antagonists. Br. J. Pharmacol. Chemother. 14:48-58 (1959).
19. Yano, K., H. Higashida, R. Inoue, and Y. Nozawa. Bradykinin-induced rapid breakdown of phosphatydylinositol 4,5-bisphosphate in neuroblastoma × glioma hybrid NG108-15 cells. J. Biol. Chem. 259:10201-10207 (1984).
20. Aramori, I., H. Nirei, M. Shoubo, K. Sogabe, K. Nakamura, H. Kojo, Y. Notsu, T. Ono, and S. Nakanishi. Subtype selectivity of a novel endothelin antagonist, FR139317, for the two endothelin receptors in transfected Chinese hamster ovary cells. Mol. Pharmacol. 43:127-131 (1993).
21. Aramori, I., M. Morikawa, J. Zenkoh, N. O'Donnell, M. Iwami, H. Kojo, Y. Notsu, M. Okuhara, S. Ono, and S. Nakanishi. Subtype-and species-selectivity of a tachykinin antagonist, FK888, for cloned rat and human tachykinin receptors. Eur. J. Pharmacol. 269:277-281 (1994).
22. Griesbacher, T., and F. Lembeck. Analysis of the antagonistic actions of Hoe140 and other novel bradykinin analogues on guinea-pig ileum. Eur. J. Pharmacol. 211:393-398 (1992).
23. 2 noncompetitive antagonist, on guinea pig tracheal bradykinin receptors. J. Pharmacol. Exp. Ther. 263:1377-1382 (1992).
24. 8]bradykinin). Eur. J. Pharmacol. 210:115-120 (1992).
25. 2 receptor antagonist, Hoe140, in isolated blood vessels from different species. Br. J. Pharmacol. 112:683-689 (1994).
26. 2 receptor antagonist, Hoe140, in the rat uterus. Eur. J. Pharmacol. 235:183-188 (1993).